Patent · US Expired

Hox-induced enhancement of in vivo and in vitro proliferative capacity and gene therapeutic methods

US5837507A · kind A · utility

6Cited by
2References
18Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 13, 1995
Grant dateNov 17, 1998
Priority date
Expiry dateNov 13, 2015

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K48/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Stem cells transduced with HOXB4 exhibit enhanced in vitro and in vivo ability for self-regeneration and generate higher-numbers of tranplantable pluripotent hematopoietic stem cells relative to control and nonmanipulated cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.